secwatch.observer — SEC 8-K summary
======================================

Issuer:     Exousia Bio, Inc. (LMMY)
CIK:        0001939937
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001683168-23-001567
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

LAMY appoints Stephen Townsend as COO; grants 250,000 shares as compensation
----------------------------------------------------------------------------

- Stephen Townsend appointed as Chief Operating Officer, effective immediately, until March 2024 annual meeting.
- Compensation consists of 250,000 shares of LAMY common stock for 12 months of service.
- Townsend brings over 20 years of finance and real estate credit expertise to the role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/0001683168-23-001567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1939937/000168316823001567/lamy_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-001567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer